Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2025 inter alia to consider and approve Dear Sir/ MadamWe wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the board of directors (the Board) of Fredun Pharmaceuticals Limited (the Company) is scheduled to beheld on Thursday 25th September 2025 to inter alia consider a proposal for issuance of equity shares and/or warrants by way of a preferential allotment in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 and the Companies Act 2013 as amended subject to such regulatory/ statutory approvals as may be required.We request you to kindly take this on record and consider the above in accordance with Regulations 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended.